New gene test cuts diagnosis time for devastating childhood brain diseases
NCT ID NCT02699190
Summary
This study tested whether using whole genome sequencing (a complete genetic map) as a first test could provide faster and more accurate diagnoses for children with rare, inherited brain disorders called leukodystrophies. Researchers compared the new approach to the standard step-by-step testing process. They found the genetic mapping method led to diagnoses much quicker and for more children than the traditional way.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADRENOLEUKODYSTROPHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.